Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response
暂无分享,去创建一个
P. Brandtzaeg | A. Waage | T. Espevik | A. Halstensen | R. Shalaby | P. Kierulf | T. Espevik | T Espevik | R Shalaby | A Halstensen | A Waage | P Brandtzaeg | P Kierulf | Terje Espevik | Refaat Shalaby | Anders Waage | Alfred Halstensen | Refaat Shalaby | Per Brandtzaeg | Alfred Halstensen
[1] P. Brandtzaeg,et al. Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .
[2] P. Brandtzaeg,et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. , 1989, The Journal of infectious diseases.
[3] C. Dinarello,et al. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. , 1984, Journal of immunology.
[4] R. Cotran,et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.
[5] W. Fiers,et al. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma , 1989, The Journal of experimental medicine.
[6] R. Ulevitch,et al. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.
[7] L. Aarden,et al. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. , 1987, Journal of immunology.
[8] N. Ruddle. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1986, Journal of immunology.
[9] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[10] T. Taniguchi,et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.
[11] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[12] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[13] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[14] E. Tuomanen. Partner drugs: a new outlook for bacterial meningitis. , 1988, Annals of internal medicine.
[15] T. Ikejima,et al. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.
[16] E. Girardin,et al. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.
[17] T. Espevik,et al. Interleukin-6 in synovial fluid from patients with arthritis. , 1989, Clinical immunology and immunopathology.
[18] A. Waage,et al. ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.
[19] J. Vilček,et al. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[20] A. Mantovani,et al. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.
[21] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[22] A. Waage,et al. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice , 1988, The Journal of experimental medicine.